01:43 PM EDT, 07/14/2026 (MT Newswires) -- NextCure ( NXTC ) will merge with privately held Avere Therapeutics in an all-stock transaction to advance Avere's lead oral IL-23 therapy, AVR-001, for inflammatory diseases, the company said.

Shares catapulted 200% as intraday trading volume soared to over 101 million from a daily average of about 103,000.

Shuttle Pharmaceuticals ( SHPH ) soared 36% after a regulatory filing showed HRT Financial bought additional shares of the firm.

More than 50.1 million shares were traded intraday, compared with a daily average of about 1.1 million.

Goldman Sachs' ( GS ) Q2 results topped analysts' estimates as a record performance in the global banking and markets business propelled revenue growth.

Shares jumped 7.6%, with intraday trading volume rising to over 2.3 million from a daily average of about 2.1 million.

Price: 1127.05, Change: +81.14, Percent Change: +7.76